Ozone therapy for diabetic foot.

Area of Science:

• Biomedical Science
• Medical Chemistry
• Pharmacology

Background:

• Diabetic foot ulcers (DFUs) pose a significant challenge to the diabetic population, often leading to high medical costs and treatment failures.
• Ozone (O3), a molecule known for its instability, has emerged as a potential alternative therapeutic agent for DFUs.
• Pharmaceutical advancements have enabled the development of various O3-based treatments, showing promising outcomes in clinical studies.

Purpose of the Study:

• To explore the efficacy of ozone (O3) therapy as an alternative treatment for diabetic foot ulcers (DFUs).
• To review the current state of O3 therapy in managing DFUs and its potential for future clinical application.

Main Methods:

• Administration of ozone (O3) therapy, typically as an O2/O3 gas mixture delivered via pressurized machines.
• Assessment, cleaning, and prompt treatment of foot ulcers are crucial for effective management.
• Review of existing clinical trials and studies investigating O3 therapy for DFUs.

Main Results:

• Numerous studies indicate promising results for O3 therapy in treating DFUs.
• The application of O2/O3 mixtures has shown positive outcomes in clinical settings.
• Prompt intervention with O3 therapy can potentially prevent severe outcomes like amputation.

Conclusions:

• Ozone (O3) therapy presents a compelling alternative therapeutic option for diabetic foot ulcers (DFUs).
• While current evidence is encouraging, further research and clinical trials are necessary to fully elucidate the role and optimize the application of O3 in DFU treatment.
• The rapid advancement of O3 therapy suggests its potential to become a leading treatment for DFUs.